The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prophylactic cranial irradiation (PCI) significantly decreases risk of brain metastases in patients with bulky, higher stage small-cell urothelial cancer.
 
Seungtaek Choi
No Relationships to Disclose
 
Matthew T Campbell
Consulting or Advisory Role - Apricity Health; AstraZeneca; Eisai; EMD Serono; Genentech; Novartis; Pfizer
Research Funding - Exelixis
 
Amishi Yogesh Shah
Honoraria - Eisai
Research Funding - Bristol-Myers Squibb; Eisai; EMD Serono
 
Neema Navai
No Relationships to Disclose
 
Ashish M. Kamat
Honoraria - Pacific Edge
Consulting or Advisory Role - Abbott Molecular; Heat Biologics; Merck; Photocure; Sanofi; Spectrum Pharmaceuticals; Telesta Therapeutics; Theralase
Research Funding - FKD Therapies; Heat Biologics; Merck; Photocure
 
Colin P.N. Dinney
Consulting or Advisory Role - FKD Therapies; Merck; NCI
Research Funding - FKD Therapies; Merck; NCI; University of Eastern Finland (Inst)
 
Quynh Nguyen
No Relationships to Disclose
 
Arlene O. Siefker-Radtke
Consulting or Advisory Role - AstraZeneca; Bavarian Nordic; BioClin Therapeutics; Bristol-Myers Squibb; Janssen; Lilly; Merck; NCCN; Nektar; Seagen
Speakers' Bureau - Genentech
Research Funding - BioClin Therapeutics; Bristol-Myers Squibb; Janssen; Michael and Sherry Sutton Fund for Urothelial Cancer; Nektar; NIH; Takeda
Patents, Royalties, Other Intellectual Property - Methods of characterizing and treating molecular subsets of muscle-invasive bladder cancer.